http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2341530-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_019d4481a09e99aa635a15f4d07f44a8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 2004-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e540dc5802a8b5f28c8f8af0085a42b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_168005e3eedccfc32ebedfc536c7aac2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bdbfd918213205408db2018b7fdb4a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc22863fb1d96b15c3346e1d3aa24e86
publicationDate 2008-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2341530-C2
titleOfInvention Thermostable crystal epirubicine hydrochloride and method of production thereof
abstract FIELD: medicine; pharmacology. n SUBSTANCE: crystal epirubicine hydrochloride of type II has diffraction pattern of X-ray powder scattering providing average diffraction angles (2θ) and relative intensities P(%), presented in the Table indicated below: n n n n EFFECT: effective application of new crystal form for cancer treatment in people and animals. n 6 cl, 7 dwg, 4 tbl, 6 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2700683-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2586117-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2630692-C2
priorityDate 2003-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3035016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451030023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425343306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19096565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500673
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16154789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449603119
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048

Total number of triples: 48.